Skip to main content
Clinical Trials/PACTR202306656398595
PACTR202306656398595
Not yet recruiting
Phase 3

Chest ultrasonographic evaluation after intrapleural Alteplase versus Streptokinase injection in Children with Empyema

Assiut University Children Hospital.0 sites75 target enrollmentMarch 7, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Respiratory
Sponsor
Assiut University Children Hospital.
Enrollment
75
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 7, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Assiut University Children Hospital.

Eligibility Criteria

Inclusion Criteria

  • Age: from1 month to18 years.
  • Gender: both sexes will be included in the study.
  • Empyema or CPPE along with evidence of septated pleural effusion on chest ultrasonography.
  • All patients will undergo chest tube insertion along with intravenous antibiotics.

Exclusion Criteria

  • Age below 1 month.
  • Patients with chronic empyema which is characterized by thickened visceral and parietal peels which hamper the ability of affected lung to re\-expand and required definitive surgical intervention.
  • Patients with bleeding tendency, recent trauma, recent operation and on anticoagulation.
  • Children with pleural empyema from tuberculosis or malignancy.
  • Children with allergy to tPA or streptokinase.
  • Children with minimal parapneumonic effusion that do not require chest tube insertion.
  • Presence of bronchopleural fistula or pyopneumothorax.

Outcomes

Primary Outcomes

Not specified

Similar Trials